B · Normal
[Hemei Pharmaceuticals' Hong Kong IPO plans to raise no more than HK$1.04 billion] On October 30, according to the Hong Kong Stock Exchange announcement, Ganzhou Hemei Pharmaceuticals Co., Ltd. planned to issue 55.2 million shares in its Hong Kong IPO, with the offering price ranging from HK$15.5 to HK$18.9 per share. Based on the upper limit of the offering price range, the company can raise up to HK$1.04 billion (approximately US$133 million). The shares are expected to be listed for trading on November 9.
Comments